Live from the NIH registry
Studies recruiting near Waterbury right now
Top 25 of 1,134 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Yale University — New Haven, Connecticut (18.2 mi)
· Sponsor: National Cancer Institute (NCI)
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Alcohol Use Disorder, Cannabis Use Disorder
N/A
Interventional 294 participants sought
UConn Health — Farmington, Connecticut (15.4 mi)
· Sponsor: Massachusetts General Hospital
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
DaVita Clinical Research — Middlebury, Connecticut (5.2 mi)
· Sponsor: R1 Therapeutics
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Yale University School of Medicine — New Haven, Connecticut (18.2 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Smilow Cancer Hospital-Waterbury Care Center — Waterbury, Connecticut (0.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
Yale Cancer Center — New Haven, Connecticut (18.2 mi)
· Sponsor: Genentech, Inc.
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Yale School Of Medicine — New Haven, Connecticut (18.2 mi)
· Sponsor: Takeda
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Yale-New Haven Hospital-Yale Cancer Center — New Haven, Connecticut (18.2 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Yale-New Haven Hospital — New Haven, Connecticut (18.2 mi)
· Sponsor: Eli Lilly and Company
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Solid Tumors, Sarcomas
Phase 1
Interventional 180 participants sought
Zai Lab Site 02030 — New Haven, Connecticut (18.2 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (13.3 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Longitudinal Neural Fingerprinting of Opioid-use Trajectories
Opioid Use Disorder
N/A
Interventional 10 participants sought
MRRC at The Anlyan Center — New Haven, Connecticut (18.2 mi)
· Sponsor: Yale University
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
EGFR Inhibitor-associated Rash
Phase 1, Phase 2
Interventional 32 participants sought
Yale University School of Medicine — New Haven, Connecticut (18.2 mi)
· Sponsor: Azitra Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — New Haven, Connecticut (18.2 mi)
· Sponsor: Sameek Roychowdhury
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Nuvance Health- Danbury Hospital — Danbury, Connecticut (24.4 mi)
· Sponsor: Duke University
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Yale University School of Medicine — New Haven, Connecticut (18.2 mi)
· Sponsor: Kura Oncology, Inc.
Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst
Cardiac Arrest
N/A
Observational 600 participants sought
Yale University — New Haven, Connecticut (18.2 mi)
· Sponsor: Boston Medical Center
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (23.0 mi)
· Sponsor: Giselle Sholler
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
Obesity
N/A
Interventional 164 participants sought
Hartford HealthCare — Hartford, Connecticut (23.0 mi)
· Sponsor: Hartford Hospital
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Hartford Hospital — Hartford, Connecticut (23.0 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Efficacy of the I-CARE Digital Health Intervention
Mental Health Disorder, Suicide Attempt
N/A
Interventional 173 participants sought
Yale — New Haven, Connecticut (18.2 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
Yale University — New Haven, Connecticut (18.2 mi)
· Sponsor: Duke University
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Yale University — New Haven, Connecticut (18.2 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Smilow Cancer Hospital-Waterbury Care Center — Waterbury, Connecticut (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Smilow Cancer Hospital-Waterbury Care Center — Waterbury, Connecticut (0.8 mi)
· Sponsor: SWOG Cancer Research Network